Fennec Pharmaceuticals's total assets for Q4 2023 were $26.86M, an increase of 41.18% from the previous quarter. FENC total liabilities were $38.49M for the fiscal quarter, a 30.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.